Cardivo guides

Retatrutide FDA approval: status, availability and how to get it safely

Updated October 30, 2026 · Wellness education, not medical advice

Is retatrutide FDA approved?

No. Retatrutide is still an investigational medicine. Eli Lilly has completed its first Phase 3 trials — TRIUMPH-1 in obesity (results May 2026) and TRIUMPH-2 in type 2 diabetes (published September 2026) — and announced that it plans to submit a Biologics License Application to the FDA in the first quarter of 2027. Other Phase 3 studies, including trials in sleep apnea, knee osteoarthritis, and heart and kidney outcomes, are still running. No regulator in the UK, EU, Canada, Australia or elsewhere has approved retatrutide either.

When will retatrutide be available?

Nobody can give an exact date, but the usual path gives a rough idea. After a company files, the FDA's standard review usually takes about 10–12 months, and a priority review or a special voucher can shorten that. If Lilly files in early 2027 and the review goes smoothly, a US approval could come around late 2027 or 2028, with other countries following on their own timelines. Even after approval, supply, insurance coverage and price will shape how quickly people can actually get it, as happened with semaglutide and tirzepatide. Treat any website claiming retatrutide is "now available" or "FDA approved" as a red flag.

Retatrutide price

There is no official price because there is no approved product. For context, Lilly's tirzepatide (Zepbound) lists at over $1,000 a month in the US before insurance or savings programs, with lower cash prices for some vial options. A future retatrutide price is likely to be set in that range, but that is a guess, not an announcement. "Retatrutide prices" quoted by online sellers are for unregulated products, not the medicine tested in trials.

Retatrutide in the UK, Canada, Australia and elsewhere

Searches like "retatrutide UK", "retatrutide BNF", "retatrutide Canada", "retatrutide Australia" and "retatrutide South Africa" all have the same answer: it is not approved and not listed in national formularies such as the BNF. In the UK it is not available on the NHS or by private prescription. Australian regulators have issued warnings after reports of serious harm, including cases of acute liver failure, linked to black-market retatrutide injections. In Latin America, searches for retatrutida para que serve or retatrutida preço point to products sold across borders — for example from Paraguay — which are equally unregulated.

Retatrutide dosage: what was used in trials

People often look for a "retatrutide dosage chart", "dosing calculator" or "how to reconstitute retatrutide". Because the drug isn't approved, there is no official dosage. In the Phase 3 trials, participants received a once-weekly injection under the skin, starting at 2 mg and increasing step by step every few weeks to a maintenance dose of 4, 9 or 12 mg, under close medical supervision with regular check-ups. Those trial schedules are research protocols, not instructions. Self-dosing from powdered "research peptide" vials — calculating your own dilution and drawing up tiny volumes — is exactly where dosing errors and hospitalizations happen, because the actual amount of drug in an unregulated vial is unknown. We don't publish reconstitution instructions or calculators for that reason.

Why you shouldn't buy retatrutide peptides online

Sites selling "reta", "reta peptides", "retatrutide peptide" or "reta pens" usually label them "for research use only" to sidestep medicine laws. Patient-safety groups and regulators warn that these products may not contain the dose they claim, may contain a different drug, may be contaminated because they weren't made in sterile conditions, and are sometimes sold with fake certificates of analysis. The FDA is tracking hundreds of adverse-event reports tied to compounded and unapproved weight-loss products, including dosing errors that needed hospital care. A 2026 study of 378 people using black-market retatrutide found they lost far less weight than trial participants — 7.2% at one year versus 15.5% in trials over the same period — suggesting many products are under-dosed or not what they claim. And because retatrutide has never been approved, no pharmacy can legally compound it. If something goes wrong, there is no manufacturer, no recall system and no proven way to know what you injected.

How to get retatrutide safely: clinical trials

The legitimate route is joining a study. Search ClinicalTrials.gov for "retatrutide" to see trials that are recruiting near you; Lilly also lists studies on its trials website. Trials cover obesity, type 2 diabetes, sleep apnea, knee osteoarthritis, kidney disease and heart outcomes. Participation is free, includes medical monitoring, and — depending on the study — you may receive retatrutide or a placebo. In the meantime, ask your doctor about approved options: tirzepatide and semaglutide already produce substantial weight loss for many people (see retatrutide vs. tirzepatide).

Track what matters while you work on your weight. Whatever medicine or plan you and your doctor choose, the numbers that change first are often your resting heart rate, your blood pressure and your blood sugar. Cardivo measures heart rate and HRV from your fingertip on the iPhone camera in about 30 seconds — no Apple Watch needed — and keeps cuff blood pressure, glucose and mood in one ad-free journal, with weekly trends and a PDF you can bring to your appointments.

Frequently asked questions

Is retatrutide FDA approved?

No. As of October 2026 retatrutide is investigational. Eli Lilly plans to submit an application to the FDA in the first quarter of 2027.

When will retatrutide be available?

If Lilly files in early 2027 and the FDA's standard review of about 10–12 months goes smoothly, US approval could come around late 2027 or 2028. Exact timing is not known.

Can I buy retatrutide legally?

No. Retatrutide is not approved anywhere, so it cannot legally be sold as a medicine or compounded by pharmacies. The only legitimate access is through a clinical trial.

What dose of retatrutide is used?

There is no approved dose. In Phase 3 trials, people started at 2 mg once weekly and increased in steps to 4, 9 or 12 mg under medical supervision.

Is retatrutide available in the UK?

No. Retatrutide is not approved in the UK, is not listed in the BNF, and is not available on the NHS or by private prescription.

Sources

• Eli Lilly — TRIUMPH-2 results in type 2 diabetes (September 2026)
• Eli Lilly — TRIUMPH-1 Phase 3 topline results (May 2026)
• ClinicalTrials.gov — TRIUMPH-1 (NCT05929066)
• Partnership for Safe Medicines — Black-market retatrutide (August 2026)
• WBAY — FDA tracking reports tied to compounded drugs and unapproved peptides

Cardivo is an ad-free iPhone app that reads heart rate and HRV from your fingertip on the camera in about 30 seconds — no Apple Watch needed — and keeps blood pressure, blood sugar, and mood in one journal you can share with your doctor as a PDF. Download on the App Store.

Keep reading